IB Net Payout Yields Model

Invest like me - only at Covestor.com

Square: Not Pricing In Q2 Weakness

By -
Square rallies near yearly highs after Q1 results.
The company should report a large decline in Q2 payments volumes and an EBITDA loss.
The stock trades at an insane 65x normalized EBITDA targets that are unlikely to be obtainable even in 2021.
Despite the obvious long-term impact of the coronavirus to Square (SQ) small business customers, the stock is now back close to yearly highs. The company faces a tough road ahead with a material impact to business in the current quarter and a questionable future. My investment thesis was bullish on a rebound at the lows near $40, but the stock is no longer appealing above $75.
Read the full article on Seeking Alpha. 

Disclosure: No position mentioned. Please review the disclaimer page for more details. 

Comments

Anonymous said…
This comment has been removed by a blog administrator.
May 15, 2020 at 11:31 AM
Anonymous said…
This comment has been removed by a blog administrator.
May 16, 2020 at 3:28 PM
Anonymous said…
This comment has been removed by a blog administrator.
May 16, 2020 at 4:48 PM
Anonymous said…
This comment has been removed by a blog administrator.
May 16, 2020 at 5:04 PM
Anonymous said…
This comment has been removed by a blog administrator.
May 16, 2020 at 5:07 PM
Anonymous said…
This comment has been removed by a blog administrator.
May 18, 2020 at 12:04 AM
Anonymous said…
This comment has been removed by a blog administrator.
May 19, 2020 at 4:08 PM
Anonymous said…
This comment has been removed by a blog administrator.
May 19, 2020 at 10:36 PM
Anonymous said…
This comment has been removed by a blog administrator.
June 2, 2020 at 2:05 PM
Anonymous said…
Drive off a cliff
June 25, 2020 at 9:40 AM
Post a Comment

Popular posts from this blog

ChargePoint: Low Quality Beat

By -
Image
  ChargePoint beat FQ2'22 revenue estimates, but the losses are mounting. The company guided up FY22 numbers partly due to acquisitions. The stock still trades at an estimated 21x FY23 number leaving limited upside for the stock and reinforcing why venture funds sold 13.8 million shares. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » After  solid FQ2'22 earnings ,  ChargePoint Holdings  ( CHPT ) has seen a nice bump in the stock. Now investors have to confront the valuation divide and deal with the past insider sales likely leading to future sales on any stock rallies. My  investment thesis  remains very Bearish on the EV charging station stock on any rallies into the mid-$20s. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Sept. 8 Be cautious when analysts strugg...
Read more

Occidental: Still Producing Too Much Oil

By -
Image
Though oil continues plunging, the oil giants continue producing more. For Q4, Occidental Petroleum (OXY) had roughly flat production. The worst part is that OXY plans to grow production by 2% to 4% in 2016. The stock has held up somewhat strong, but the inability to turn off the spigot remains troubling. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disc...
Read more